Table 1

Inhibition of purified ADA and ADA activity in intact HACs and human RBCs by EHNA and its analogs

CompoundSoluble ADA Type IX calf spleenWhole cells IC50
Human HACsHuman RBCs
KinM μM
EHNA9.31.45  ± 0.11.20  + 0.7
CPC-4028.012.72  ± 3.2N.D.
CPC-4052.72.61  ± 0.50.22  + 0.1
CPC-4060.950.75  ± 0.3N.D.
CPC-4077.44.08  ± 0.9N.D.
CPC-410N.D.270.65  ± 65.1N.D.
  • For experimental details, see the text.

  • N.D. = not determined.